Search Results | MSF Science Portal

Journal Article

|

Research

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Sani O, et al.

2025-05-22 • PLOS One

BACKGROUND

The management of post-meningitis sequelae is a priority in the WHO Roadmap to Defeat Meningitis by 2030. Nonetheless, the prevalence of sequelae in ...

Journal Article

|

Research

Rasti R, Kumbakumba E, Nanjebe D, Mlotshwa P, Nassejje M, et al.

2025-03-22 • BMC Infectious Diseases

BACKGROUND

In low-resource settings, limited laboratory capacity adds to the burden of central nervous system (CNS) infections in children and spurs overuse of ...

Conference Material

|

Poster

Yakum MN, Gignoux E

2024-05-23 • Epicentre Scientific Day 2024

Journal Article

|

Research

Ditondo P, Luemba A, Chuy RI, Mucinya G, Ade S

2023-08-01 • Public Health Action

CONTEXTE
Médecins Sans Frontières Belgique a mis en place des diagnostics au point de service (DPS) pour le dépistage précoce d’un VIH avancé, et en présence de celle-ci, d’une TB et...

Conference Material

|

Abstract

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O, et al.

2023-06-07 • MSF Scientific Day International 2023

INTRODUCTION
MSF supported Niger’s Ministry of Health (MoH) in responding to a serogroup C meningococcal meningitis epidemic in Magaria and Dungass Districts in 2022. WHO’s global ro...

Conference Material

|

Slide Presentation

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O, et al.

2023-06-07 • MSF Scientific Day International 2023

Journal Article

|

Case Report/Series

Sood R, Walo C, Burton R, Khalife M, Dicko A, et al.

2023-02-09 • Journal of Medical Case Reports

BACKGROUND
Gram-negative bacillary meningitis remains a rare occurrence, even in patients with human immunodeficiency virus. Current literature only describes anecdotal cases of spon...

Journal Article

|

Commentary

Burry J, Casas CP, Ford NP

2022-08-29 • Clinical Infectious Diseases

Cryptococcal meningitis accounts for 1 in 5 AIDS-related deaths globally. World Health Organization guidelines strongly recommend a single high dose of liposomal amphotericin B as part o...

Journal Article

|

Research

Rose AMC, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL, et al.

2010-06-11 • PLOS One

Meningococcal meningitis outbreaks occur every year during the dry season in the "meningitis belt" of sub-Saharan Africa. Identification of the causative strain is crucial before launchi...

Journal Article

|

Review

Ali A, Jafri RZ, Messonnier N, Tevi-Benissan C, Durrheim DN, et al.

2014-01-01 • Pathogens and Global Health

A number of countries now include meningococcal vaccines in their routine immunization programs. This review focuses on different approaches to including meningococcal vaccines in countr...

Journal Article

|

Research

Govender NP, Meintjes GA, Mangena PM, Nel J, Potgieter S, et al.

2019-11-08 • Southern African Journal of HIV medicine

Journal Article

|

Research

Bharti N, Broutin H, Grais RF, Ferrari MJ, Djibo A, et al.

2011-10-05 • Epidemiology and Infection

Throughout the African meningitis belt, meningococcal meningitis outbreaks occur only during the dry season. Measles in Niger exhibits similar seasonality, where increased population den...

Journal Article

|

Research

Rose AMC, Gerstl S, Mahamane AE, Sidikou F, Djibo S, et al.

2009-10-05 • PLOS One

The Pastorex((R)) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt". Earlier evaluati...

Journal Article

|

Research

Parikh S, Newbold L, Slater S, Moschioni M, Lucidarme J, et al.

2017-07-01 • Lancet Infectious Diseases

BACKGROUND
The UK introduced 4CMenB-a multicomponent vaccine against serogroup B meningococcal disease-into the national infant immunisation programme in September, 2015. The Meningo...

Journal Article

|

Research

Deiss R, Loreti C, Gutierrez AG, Filipe E, Tatia M, et al.

2021-04-26 • PLOS One

BACKGROUND
Cryptococcal meningitis is a leading cause of HIV-related mortality in sub-Saharan Africa, however, screening for cryptococcal antigenemia has not been universally impleme...

Journal Article

|

Research

Shroufi A, Govender NP, Meintjes GA, Black JM, Nel J, et al.

2020-06-01 • International Journal of Infectious Diseases

BACKGROUND
Cryptococcal Meningitis (CM) is estimated to cause 181,000 deaths annually; with the majority occurring in Sub Saharan Africa. Flucytosine is recommended by the World Heal...

Journal Article

|

Commentary

Loyse A, Burry J, Cohn J, Ford NP, Chiller T, et al.

2018-10-18 • Lancet Infectious Diseases

In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-related cryptococcal disease. Two strategies are recommended to reduce the high mortality associated w...

Journal Article

|

Commentary

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, et al.

2017-06-29 • PLOS Neglected Tropical Diseases

Journal Article

|

Research

Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, et al.

2014-12-29 • PLoS Currents

The Democratic Republic of Congo (DRC) has committed to eliminate measles by 2020. In 2013, in response to a large outbreak, Médecins Sans Frontières conducted a mass vaccination campaig...

Journal Article

|

Short Report

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F, et al.

2015-01-01 • Emerging Infectious Diseases

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated...

Science Portal

Sequelae following an epidemic of meningococcal meningitis in Niger in 2022

Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in southwestern Uganda

Factors associated with death among meningitis patients during the 2022-2023 epidemic in Jigawa State, Nigeria

Contribution des diagnostics au points de service dans l’identification de la maladie à VIH avancée

Sequelae following an epidemic of meningococcal meningitis in Niger

Sequelae following an epidemic of meningococcal meningitis in Niger

Spontaneous nosocomial Proteus mirabilis meningitis in a Human Immunodeficiency Virus (HIV)-infected adult patient: a case report

Access to medicines for treating people With cryptococcal meningitis

Meningitis Dipstick Rapid Test: Evaluating Diagnostic Performance During an Urban Neisseria Meningitidis Serogroup A Outbreak, Burkina Faso, 2007

Global practices of meningococcal vaccine use and impact on invasive disease

Southern african HIV clinicians society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update

Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles

Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique

Time to embrace access programmes for medicines: Lessons from the South African flucytosine access programme

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Cryptococcal meningitis: A neglected NTD?

Measles vaccination coverage survey in Moba, Katanga, Democratic Republic of Congo, 2013: need to adapt routine and mass vaccination campaigns to reach the unreached

Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013